11 results about "Regulation hormone" patented technology

A diabetes management system optimizes glucoregulatory hormone delivery using a connected glucoregulatory hormone delivery system and a computing device with a processor and non-transitory memory. The system receives glucose management data (glucose, insulin delivery, heart rate, or carbohydrate consumption data) from sensors. A digital twin metabolic model is selected and initialized based on the received data. The system simulates diabetes treatment interventions to predict glucose dynamics and determines an optimized glucoregulatory hormone parameter (e.g., insulin dose or increment that minimizes hyperglycemia and hypoglycemia risk). The determined glucoregulatory hormone parameter is transmitted to the connected glucoregulatory hormone delivery system, which may include an automated insulin delivery (AID) system or a connected insulin pen system, for implementation. By integrating real-time physiological data with predictive metabolic modeling, the system enhances glucoregulatory hormone therapy, providing personalized adjustments to improve glucose control.

The invention discloses a synergistic anti-oxidation urolithin A composition and application thereof in improving the ovarian function direction, and relates to the technical field of biological medicine, and the active ingredients of the composition comprise 10-100 parts of urolithin A and 6-40 parts of coenzyme Q10. According to the composition disclosed by the invention, the used raw materials are food-grade raw materials such as urolithin A and coenzyme Q10, and the urolithin A and the coenzyme Q10 are matched within a certain range, so that a good synergistic interaction effect can be achieved, and the composition has a good antioxidant effect; meanwhile, the composition also has the effects of effectively improving the ovarian reserve function, regulating the hormone level, improving menstruation, skin, emotion, sleep and the like at a low dosage level, and is effective and safe.

The present application relates to a kind of skin care composition for improving female menopausal aging and its application, the skin care composition for improving female menopausal aging includes the following components: conotoxin peptide, bakuchiol, alfalfa extract and radix pseudostellariae extract, the weight ratio of conotoxin peptide, bakuchiol, alfalfa extract and radix pseudostellariae extract is (0.1-5) :(0.1-3) :(0.1-5) :(0.1-3). The four are by means of inhibiting neurotransmitter, regulating hormone etc., enhance skin health, effectively improve the problem of menopausal female skin aging, make skin firm and smooth.

Nutritional supplements and compositions for activating the GLP‑1 peptide and / or other hormones in a subject in order to regulate blood sugar, weight, and hunger of the subject are described in this application. The compositions include a first nutritional supplement containing specific amounts of hydrolyzed yeast, acacia gum powder, citrus bioflavonoids, cinnamon bark, and eggplant whole vegetable. The compositions also include a second nutritional supplement containing specific amounts of medium chain triglycerides, resistant potato starch, resistant tapioca starch, kombucha, guar gum, blueberry juice powder, cranberry fruit powder, and grape seed extract. A third composition includes the first and second nutritional supplements containing these ingredients in sufficient amounts to regulate the GLP‑1 hormone and / or other metabolic hormones. These compositions can increase the total GLP‑1 production up to about 220%. Other embodiments are also described.

The invention relates to the technical field of biological medicine and health care, in particular to a production method and formula for balancing female hormone level, and the production method comprises the following steps: mixing plant extract, microbial metabolite and functional lipid to form a basic active mixture, adding a trace element compound, and performing microencapsulation treatment. The composition comprises an evening primrose oil extract, a soy isoflavone extract and the like, and accurate regulation and control are realized by regulating a hormone synthesis route and signal transduction. The invention further provides an application method and an effect evaluation mode, the formula proportion can be adjusted according to individual hormone detection results, and the composition is suggested to be taken after breakfast so as to improve the absorption efficiency. The personalized health management requirement can be efficiently and safely met, and meanwhile the long-term effect stability is improved.

The invention relates to the technical field of traditional Chinese medicine compositions, in particular to a traditional Chinese medicine composition for treating plateau hypoxia-male reproductive injury as well as a preparation method and application of the traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from the following raw materials: rhizoma polygonati, radix angelicae sinensis and radix astragali seu hedysari. The traditional Chinese medicine composition can reduce oxidative stress in vivo, regulate hormone level and improve sperm activity, thereby improving plateau hypoxia-male reproductive injury.

A system and method for tuning hormone receptors through the dynamic intravenous introduction of a hormone in a manner that mimics a target physiological secretion cadence of that hormone is presented herein. In particular, a dosing model is developed with a desired goal of creating a hormone delivery plan with a dosing waveform that resembles a waveform associated with the target physiological secretion cadence of the hormone. Several bolus delivery specifications, including volume, frequency, and pressure, are dynamically defined such that, over a specified period of time, the bolus introductions create the desired dosing waveform. The dosing model is then executed through a plurality of successive and dynamic intravenous exogenous bolus introductions of the hormone according to the plurality of bolus delivery specifications.

The invention relates to the technical field of biological medicine, in particular to a novel application of a burdock-fructus forsythiae medicine pair and a medicine containing the burdock-fructus forsythiae medicine pair and used for adjusting the hormone level, and finds that the burdock-fructus forsythiae medicine pair can improve the hormone level of female mice and male rats for the first time. Tests finally find that when the mass ratio of the burdock alcohol extract to the fructus forsythiae alcohol extract is 1: 2, the hormone level adjusting effect is optimal, the inhibition effect of cyclophosphamide on splenic lymphocytes can be effectively relieved, meanwhile, the anti-inflammatory effect is optimal, and the pharmaceutical composition is suitable for clinical application. Therefore, the effect of treating the acne can be achieved by independently using the burdock alcohol extract and the fructus forsythiae alcohol extract, and the problems that a traditional Chinese medicine composition is complex in compatibility, high in medication cost, large in side effect and the like are solved.

Nutritional supplements and compositions for activating the GLP-1 peptide and / or other hormones in a subject in order to regulate blood sugar, weight, and hunger of the subject are described in this application. The compositions include a first nutritional supplement containing specific amounts of hydrolyzed yeast, acacia gum powder, citrus bioflavonoids, cinnamon bark, and eggplant whole vegetable. The compositions also include a second nutritional supplement containing specific amounts of medium chain triglycerides, resistant potato starch, resistant tapioca starch, kombucha, guar gum, blueberry juice powder, cranberry fruit powder, and grape seed extract. A third composition includes the first and second nutritional supplements containing these ingredients in sufficient amounts to regulate the GLP-1 hormone and / or other hormones. These compositions can increase the total GLP-1 production up to about 200%. Other embodiments are also described.

The invention relates to pediococcus pentosaceus BGI-N8, a composition containing the pediococcus pentosaceus BGI-N8 as an effective component, and application of the pediococcus pentosaceus BGI-N8, and the preservation number of the pediococcus pentosaceus BGI-N8 is CCTCC (China Center For Type Culture Collection) NO: M20232703. The pediococcus pentosaceus contains a nucleotide sequence of an rpoA gene as shown in SEQ ID NO: 5 and a nucleotide sequence of a pyrG gene as shown in SEQ ID NO: 6. The pediococcus pentosaceus BGI-N8 provided by the embodiment of the invention has good safety and excellent gastrointestinal tract environment tolerance, and can reduce the calorie conversion rate of food by increasing the serum level of energy regulation hormone casein peptide, thereby preventing or treating metabolic diseases such as hyperlipidemia, diabetes mellitus, obesity, fatty liver, hepatic fibrosis and the like.

A system and method for tuning hormone receptors through the dynamic intravenous introduction of a hormone in a manner that mimics a target physiological secretion cadence of that hormone is presented herein. In particular, a dosing model is developed with a desired goal of creating a hormone delivery plan with a dosing waveform that resembles a waveform associated with the target physiological secretion cadence of the hormone. Several bolus delivery specifications, including volume, frequency, and pressure, are dynamically defined such that, over a specified period of time, the bolus introductions create the desired dosing waveform. The dosing model is then executed through a plurality of successive and dynamic intravenous exogenous bolus introductions of the hormone according to the plurality of bolus delivery specifications.